1.
|
15 p, 3.0 MB |
Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL
/
Rejeski, Kai (Bavarian Cancer Research Center (Alemanya)) ;
Blumenberg, Viktoria (Bavarian Cancer Research Center (Alemanya)) ;
Iacoboni, Gloria (Vall d'Hebron Institut d'Oncologia) ;
López Corral, Lucia (Centro de Investigación del Cáncer-IBMCC (Espanya)) ;
Kharboutli, Soraya (University Hospital Erlangen (Alemanya)) ;
Hernani, Rafael (Hospital Clínico Universitario (Espanya)) ;
Petrera, Agnese (German Research Center for Environmental Health (Alemanya)) ;
Müller, Niklas (University Hospital (Alemanya)) ;
Hildebrand, Friederike (University Hospital (Alemanya)) ;
Frölich, Lisa (German Cancer Consortium (Alemanya)) ;
Karschnia, Philipp (University Hospital (Alemanya)) ;
Schmidt, Christian (University Hospital (Alemanya)) ;
Cordas dos Santos, David M. (German Cancer Consortium (Alemanya)) ;
Piñana, José Luis (Hospital Clínic Universitari (València)) ;
Müller, Fabian (University Hospital Erlangen (Alemanya)) ;
Martin, Ana Africa (Centro de Investigación del Cáncer-IBMCC (Espanya)) ;
Dreyling, Martin (University Hospital (Alemanya)) ;
von Bergwelt-Baildon, Michael (Bavarian Cancer Research Center (Alemanya)) ;
Barba, Pere (Vall d'Hebron Institut d'Oncologia) ;
Subklewe, Marion (Bavarian Cancer Research Center (Alemanya)) ;
Bücklein, Veit (Bavarian Cancer Research Center (Alemanya)) ;
Universitat Autònoma de Barcelona
Early fever after chimeric antigen receptor T-cell (CAR-T) therapy can reflect both an infection or cytokine release syndrome (CRS). Identifying early infections in the setting of CRS and neutropenia represents an unresolved clinical challenge. [...]
2023 - 10.1097/HS9.0000000000000858
HemaSphere, Vol. 7 (april 2023)
|
|
2.
|
5 p, 765.8 KB |
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
/
Iacoboni, Gloria (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Rejeski, Kai (Department of Medicine III, University Hospital, LMU Munich, Munich, Germany) ;
Villacampa Javierre, Guillermo (Vall d'Hebron Institut d'Oncologia) ;
van Doesum, Jaap A. (Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands) ;
Chiappella, Annalisa (Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milano, Italy) ;
Bonifazi, Francesca (IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia "Seràgnoli", Bologna, Italy) ;
López Corral, Lucia (Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain) ;
van Aalderen, Michiel (Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands) ;
Kwon, Mi (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Martínez-Cibrian, Nuria (Hospital Clínic i Provincial de Barcelona) ;
Bramanti, Stefania (Istituto Clinico Humanitas IRCCS, Rozzano, Italy) ;
Reguera-Ortega, Juan Luis (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Camacho-Arteaga, Lina (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Schmidt, Christian (Department of Medicine III, University Hospital, LMU Munich, Munich, Germany) ;
Marín-Niebla, Ana (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Kersten, Marie José (Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands) ;
Martín García-Sancho, Alejandro (Instituto de Investigación Biomédica de Salamanca) ;
Zinzani, Pier Luigi (Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy) ;
Corradini, Paolo (Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milano, Italy) ;
van Meerten, Tom (Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands) ;
Subklewe, Marion (Department of Medicine III, University Hospital, LMU Munich, Munich, Germany) ;
Barba, Pere (Universitat Autònoma de Barcelona. Departament de Medicina)
2022 - 10.1182/bloodadvances.2021006922
Blood advances, Vol. 6 (june 2022) , p. 3606-3610
|
|
3.
|
7 p, 884.3 KB |
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
/
Rejeski, Kai (German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany) ;
Burchert, Andreas (Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany) ;
Iacoboni, Gloria (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Sesques, Pierre (Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, France) ;
Fransecky, Lars (Universitätsklinikum Schleswig-Holstein (Alemanya)) ;
Bücklein, Veit (Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany) ;
Trenker, Corinna (Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany) ;
Hernani, Rafael (Hospital Clínic Universitari (València)) ;
Naumann, Ralph (Medical Department III-Hematology and Oncology, St. Marien-Krankenhaus Siegen, Siegen, Germany) ;
Schäfer, Jonas (Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany) ;
Blumenberg, Viktoria (German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany) ;
Schmidt, Christian (Department of Medicine III, Hematology and Oncology, University Hospital, LMU Munich, Munich, Germany) ;
Sohlbach, Kristina (Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany) ;
von Bergwelt-Baildon, Michael (German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany) ;
Bachy, Emmanuel (Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, France) ;
Barba, Pere (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Subklewe, Marion (German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany)
2022 - 10.1182/bloodadvances.2022007776
Blood advances, Vol. 6 (august 2022) , p. 4719-4725
|
|